• <td id="wjkko"></td>
    <code id="wjkko"><ol id="wjkko"></ol></code>
    <pre id="wjkko"><ruby id="wjkko"><menu id="wjkko"></menu></ruby></pre>
    <table id="wjkko"></table><track id="wjkko"><ruby id="wjkko"></ruby></track>

    <td id="wjkko"><ruby id="wjkko"></ruby></td>

          1. Pharmaceutical Manufacturing Industry Profile

            Report Page Length: 10-12
            Last Quarterly Update: 9/7/2020
            SIC Codes: 283
            NAICS Codes: 3254
            Chapters Include:
            Industry Overview Trends & Challenges Industry Forecast
            Quarterly Industry Update Call Prep Questions Website & Media Links
            Business Challenges Financial Information Glossary & Acronyms
            View Full Sample Add To Cart

            Excerpt from Pharmaceutical Manufacturing Industry Profile

            Companies in this industry manufacture and process pharmaceutical products. Major companies include Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Merck & Co, and Pfizer (all based in the US), as well as AstraZeneca (UK), Bayer (Germany), GlaxoSmithKline (UK), Novartis (Switzerland), Roche Holding (Switzerland), and Sanofi (France).

            Annual worldwide revenue from pharmaceutical manufacturing is about $1 trillion and is expected to reach $1.1 trillion by 2024, according to a 2020 forecast from market intelligence firm IQVIA. Worldwide spending on medicines is increasing due to economic growth in developing nations and the rising cost of specialty drugs. The US, the EU, and Switzerland remain the largest importers of pharmaceuticals, but manufacturers are targeting emerging economies for growth.

            The US pharmaceutical manufacturing industry includes about 2,400 establishments (single-location companies and units of multi-location companies) with combined annual revenue of about $230 billion.

            COMPETITIVE LANDSCAPE

            Pharmaceutical manufacturers compete to discover and commercialize ever-more effective medicines. Companies focus on the most profitable markets, where demand for treatment is high. Key areas of development include cardiovascular, cancer, and diabetes medications, as increases in the number of elderly and obese patients fuel disease growth in these categories. Companies may also focus on rare disease categories, where available treatments are limited or nonexistent and opportunities exist for expedited approvals and profitable pricing.

            The traditional drug manufacturing industry increasingly overlaps with the biotechnology industry, which is a source of many new medical ...

             
            View Full Sample Add To Cart Return to the Industry Profile Menu
            Add To Cart

            Focus Profiles

            Complement this Industry Profile by purchasing a Focus Profile. Pharmaceutical Manufacturing has one Focus Profiles that can help you better understand this industry:

            Would you or your company benefit from having unlimited access to First Research's industry intelligence tools?

            Learn More About Subscription Options
             
            韩国电影-韩国三级-韩国r级电影-韩国理论片在线-天天影视网 <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <蜘蛛词>| <文本链> <文本链> <文本链> <文本链> <文本链> <文本链>